
December 21, 2022
UNC Health Provider Ushers in First FDA-Approved Medication for Eosinophilic Esophagitis
Evan Dellon, MD, MPH, a professor in the Department of Medicine and director of the Center for Esophageal Diseases and Swallowing, co-leads effort to approve an allergy drug, dupilumab, for the treatment in adults and adolescents with eosinophilic esophagitis.